Search Results - "LUBBERINK, Mark"

Refine Results
  1. 1

    Kinetic Models for Measuring P-glycoprotein Function at the Blood-Brain Barrier with Positron Emission Tomography by Lubberink, Mark

    Published in Current pharmaceutical design (01-01-2016)
    “…P-glycoprotein function is associated with a number of neurodegenerative and psychiatric diseases as well as with pharmacoresistance to for example…”
    Get more information
    Journal Article
  2. 2

    Studies of a Next-Generation Silicon-Photomultiplier-Based Time-of-Flight PET/CT System by Hsu, David F C, Ilan, Ezgi, Peterson, William T, Uribe, Jorge, Lubberink, Mark, Levin, Craig S

    Published in Journal of Nuclear Medicine (01-09-2017)
    “…This article presents system performance studies for the Discovery MI PET/CT system, a new time-of-flight system based on silicon photomultipliers. System…”
    Get full text
    Journal Article
  3. 3

    EANM procedural guidelines for PET/CT quantitative myocardial perfusion imaging by Sciagrà, Roberto, Lubberink, Mark, Hyafil, Fabien, Saraste, Antti, Slart, Riemer H. J. A., Agostini, Denis, Nappi, Carmela, Georgoulias, Panagiotis, Bucerius, Jan, Rischpler, Christoph, Verberne, Hein J.

    “…The use of cardiac PET, and in particular of quantitative myocardial perfusion PET, has been growing during the last years, because scanners are becoming…”
    Get full text
    Journal Article
  4. 4

    Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [68Ga]ABY-025 Affibody PET/CT by Sörensen, Jens, Velikyan, Irina, Sandberg, Dan, Wennborg, Anders, Feldwisch, Joachim, Tolmachev, Vladimir, Orlova, Anna, Sandström, Mattias, Lubberink, Mark, Olofsson, Helena, Carlsson, Jörgen, Lindman, Henrik

    Published in Theranostics (2016)
    “…Positron Emission Tomography (PET) imaging of HER2 expression could potentially be used to select patients for HER2-targed therapy, predict response based on…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Application of positron emission tomography in psychiatry—methodological developments and future directions by Cervenka, Simon, Frick, Andreas, Bodén, Robert, Lubberink, Mark

    Published in Translational psychiatry (14-06-2022)
    “…Mental disorders represent an increasing source of disability and high costs for societies globally. Molecular imaging techniques such as positron emission…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Automatic generation of absolute myocardial blood flow images using [15O]H2O and a clinical PET/CT scanner by Harms, Hendrik J., Knaapen, Paul, de Haan, Stefan, Halbmeijer, Rick, Lammertsma, Adriaan A., Lubberink, Mark

    “…Purpose Parametric imaging of absolute myocardial blood flow (MBF) using [ 15 O]H 2 O enables determination of MBF with high spatial resolution. The aim of…”
    Get full text
    Journal Article
  13. 13

    Acute nicotine exposure blocks aromatase in the limbic brain of healthy women: A [11C]cetrozole PET study by Dubol, Manon, Immenschuh, Jana, Jonasson, My, Takahashi, Kayo, Niwa, Takashi, Hosoya, Takamitsu, Roslin, Sara, Wikström, Johan, Antoni, Gunnar, Watanabe, Yasuyoshi, Lubberink, Mark, Biegon, Anat, Sundström-Poromaa, Inger, Comasco, Erika

    Published in Comprehensive psychiatry (01-05-2023)
    “…Of interest to women's mental health, a wealth of studies suggests sex differences in nicotine addiction and treatment response, but their psychoneuroendocrine…”
    Get full text
    Journal Article
  14. 14

    PET/MRI of glucose metabolic rate, lipid content and perfusion in human brown adipose tissue by Lundström, Elin, Andersson, Jonathan, Engström, Mathias, Lubberink, Mark, Strand, Robin, Ahlström, Håkan, Kullberg, Joel

    Published in Scientific reports (22-07-2021)
    “…This study evaluated the MRI-derived fat fraction (FF), from a Cooling-reheating protocol, for estimating the cold-induced brown adipose tissue (BAT) metabolic…”
    Get full text
    Journal Article
  15. 15

    Parametric imaging and quantitative analysis of the PET amyloid ligand [18F]flutemetamol by Heurling, Kerstin, Buckley, Chris, Van Laere, Koen, Vandenberghe, Rik, Lubberink, Mark

    Published in NeuroImage (Orlando, Fla.) (01-11-2015)
    “…The amyloid imaging PET tracer [18F]flutemetamol was recently approved by regulatory authorities in the US and EU for estimation of β-amyloid neuritic plaque…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology by Jonasson, My, Wall, Anders, Chiotis, Konstantinos, Saint-Aubert, Laure, Wilking, Helena, Sprycha, Margareta, Borg, Beatrice, Thibblin, Alf, Eriksson, Jonas, Sörensen, Jens, Antoni, Gunnar, Nordberg, Agneta, Lubberink, Mark

    Published in The Journal of nuclear medicine (1978) (01-04-2016)
    “…Because a correlation between tau pathology and the clinical symptoms of Alzheimer disease (AD) has been hypothesized, there is increasing interest in…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Image reconstruction methods affect software-aided assessment of pathologies of [18F]flutemetamol and [18F]FDG brain-PET examinations in patients with neurodegenerative diseases by Lindström, Elin, Oddstig, Jenny, Danfors, Torsten, Jögi, Jonas, Hansson, Oskar, Lubberink, Mark

    Published in NeuroImage clinical (01-01-2020)
    “…•[18F]Flutemetamol and [18F]FDG image reconstruction.•Software-aided assessment of neurodegenerative disease patients.•New developments in brain PET image…”
    Get full text
    Journal Article